Lupin buys two brands from Sanofi in Europe, Canada Ruchika Sharma5 Jun 2024 3:00 PM ISTMumbai: Lupin Limited, a global pharma major, today announced that Lupin Atlantis Holdings SA, the Company's European hub...
Lupin arm unveils Luforbec 100/6 for adult asthma, COPD treatment in Germany Ruchika Sharma22 July 2023 2:30 PM ISTMumbai: Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / ...
Lupin launches asthma, COPD drug Luforbec in UK Ruchika Sharma24 Aug 2021 5:13 PM ISTLuforbec is first branded generic alternative to Fostair 100/6 g pMDI for treatment of Asthma and COPD.
Lupin gets UK marketing authorization for first branded generic of Fostair Ruchika Sharma15 Jun 2021 1:16 PM ISTMumbai: Global pharma major, Lupin Limited, has recently announced that the company's UK subsidiary, Lupin Healthcare (UK) Limited has received...
